Back to search

University of Sheffield

Decision analytic modelling to inform policy and research decisions on the use of risk assessment models to select patients at risk of venous thromboembolism for pharmacologic prophylaxis

Abstract

dc:description.abstract

Pharmacological thromboprophylaxis can be used to reduce the risk of venous thromboembolism (VTE), but it is costly and is associated with an increased risk of bleeding. Selecting higher-risk individuals for thromboprophylaxis using a risk-assessment model (RAM) has the potential to be cost-effective if the population selected has a more favourable balance of costs, benefits and harms. This thesis discusses the use of decision-analytic modelling to assess the cost-effectiveness of RAM-based prophylaxis in several distinct populations: outpatients having lower limb immobilisation following injury, medical and surgical inpatients, and women who are pregnant or in the puerperium. In each population, RAM-based prophylaxis was compared against prophylaxis for all and prophylaxis for none. The RAMs modelled were those validated for use in each specific population. Where data allowed, the analyses compared alternative RAMs, alternative RAM cut-offs for prophylaxis and the optimal trade-off between RAM sensitivity and specificity in a given population. Cost-effectiveness was assessed by comparing lifetime costs and quality-adjusted life years from an NHS and personal social services perspective. The cost-effectiveness of RAM-based prophylaxis varied across the populations considered due to differences in the risks of VTE and the differences in the prognostic accuracy of the available RAMs. In postpartum women, RAM-based prophylaxis was not cost-effective compared to no prophylaxis due to the very low risk of VTE and the poor specificity of the available RAMs. In people having lower limb immobilisation, a RAM would need to have a sensitivity of between 84% and 89% and a specificity of between 46% and 55% for RAM-based prophylaxis to be cost-effective. Whereas in medical and surgical inpatients, a RAM would need to have very high sensitivity for RAM-based prophylaxis to be more cost-effective than prophylaxis for all. The cost-effectiveness of RAM-based prophylaxis was most uncertain in high-risk antepartum women and obese postpartum women.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Davis, Sarah
Advisor dc:contributor.advisor
  • Goodacre, Steve
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
15/187/06
NIHR127454
NIHR131021

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Davis, Sarah. Decision analytic modelling to inform policy and research decisions on the use of risk assessment models to select patients at risk of venous thromboembolism for pharmacologic prophylaxis. doctoral thesis, University of Sheffield, 2026.